Satori Pharmaceuticals' Series B Round

Satori Pharmaceuticals raised a round of funding on January 24, 2011.

Satori Pharmaceuticals is a developing therapeutics for Alzheimer's Disease (AD). The company is developing small molecule compounds that are orally active and designed for chronic dosing in seniors. …

Articles about Satori Pharmaceuticals' Series B Round: